ALL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ALL
Jul 25, 2024, 21:25 |
Blog
Elad Sharon: Another win for patients with ALL
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X: "Another win for…
Jul 12, 2024, 16:59 |
Insight
Naveen Pemmaraju: Two of the finest people I have ever known
Naveen Pemmaraju shared a post on X: “Just landed MD Education AML-ALL US Focus meeting…
Jul 8, 2024, 17:25 |
Drugs
Fadi Haddad: US FDA approval of BLINCYTO in patients with ALL
Fadi Haddad, Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center shared…
Jul 3, 2024, 06:58 |
Blog
More young people are being affected by cancer than ever before
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "More young people…
Jun 28, 2024, 14:06 |
Blog
Vincent Rajkumar: Cure is a simple word. But there is confusion when it comes to cancer
Vincent Rajkumar shared a post on X: “Cure is a simple word. But there is…
Jun 17, 2024, 15:06 |
Dialogues
Oncodaily Dialogues #9 István Peták/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Jun 4, 2024, 13:59 |
Blog
Nearly 29 years since her diagnosis, Browne shares her story - St. Jude Children's Research Hospital
St. Jude Children's Research Hospital recently shared a post on LinkedIn: "Looking back at her…
May 21, 2024, 07:10 |
Blog
Nitin Jain: Brief summary slide with some general concepts about assay depth
Nitin Jain, Professor of Medicine in the Department of Leukemia at The University of Texas MD…
May 5, 2024, 05:58 |
Cancer Types
Acute Lymphoblastic Leukemia (ALL) in children: What patients and caregivers should know about
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children, accounting…
May 3, 2024, 06:01 |
Blog
The 2023 recommendations for the initial management of adult ALL by The European Leukemia Net - ALL Hub
ALL Hub shared on X: “The European Leukemia Net (ELN) has published the 2023 recommendations…
May 2, 2024, 16:57 |
Societies
Gender Neutrality in Immunization! - Medicaid CF Programs
Medicaid CF Programs shared on their X page: “Join us for a thought-provoking InstaLive session…
May 2, 2024, 01:54 |
Blog
Manas Kalra: The change in ALL therapy is happening in front of us
Manas Kalra, Consultant in the Department of Paediatric Hemato-Oncology at Sir Ganga Ram Hospital, shared…
Apr 29, 2024, 16:55 |
Blog
Nita Radhakrishnan: Wonderful talk by Dr. Anil Handoo
Nita Radhakrishnan shared a post on X: “Multiple signs for hematogones while evaluating Minimal residual…
Apr 22, 2024, 12:42 |
Blog
Rob Winn: My sincerest thanks to the White House Office of Science and Technology Policy for inviting me to be a panelist at The White House Minority Health Forum today
Rob Winn, Director of VCU Massey Comprehensive Cancer Center, shared a post on LinkedIn: “I want…
Apr 4, 2024, 14:31 |
Blog
Isabel Mestres: I am very proud of the organizational culture we are building together with the C/Can team
Isabel Mestres, CEO at City Cancer Challenge Foundation, shared a post on LinkedIn: “When City…
Feb 26, 2024, 17:54 |
Blog
Andres Gomez: Retrospective data continues to favor haploidentical in adults with Acute Lymphocytic Leukemia
Andres Gomez, Associate Professor at the Autonomous University of Nuevo León, recently posted on X/Twitter:…
Jan 19, 2024, 18:16 |
Blog
Satya Prakash Yadav: Is chemotherapy free treatment of leukemia possible?
Satya Prakash Yadav, Director of Paediatric Hemato-Oncology and Bone Marrow Transplant at Medical and Haemato-Oncology…
Jan 16, 2024, 11:37 |
Insight
Jayastu Senapati: Check out our SOHO State of the Art Review on Acute Lymphoblastic Leukemia
Jayastu Senapati, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Jan 9, 2024, 13:10 |
Blog
Hagop Kantarjian: Updates on the management of Ph-positive ALL
Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared on X/Twitter: “Updates on the management…
Jan 1, 2024, 04:39 |
Blog
Talha Badar: Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL here
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "Long-Term Results of the…
Dec 8, 2023, 12:47 |
Insight
Talha Badar: A few selected ALL abstracts to watch for at ASH23
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Oct 25, 2023, 18:04 |
Insight
Talha Badar: Moving immunotherapy upfront in B-cell ALL
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on Twitter:…
Oct 15, 2023, 18:06 |
Blog
Adam Esbenshade: Outstanding talk by Caitlyn Duffy from St. Jude at SIOP ALL session
Quoting Adam Esbenshade, Associate Professor of Pediatrics at the Vanderbilt University Medical Center, on X/Twitter:…
Sep 28, 2023, 18:16 |
Blog
We're proud to have partnered with Harley Staples to fund new research into why leukaemia relapses. - Children’s Cancer and Leukaemia Group
Children’s Cancer and Leukaemia Group shared on their X/Twitter page: ''We're proud to have partnered…
All:
24
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube